Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions
- Extensive Stage Small Cell Lung Cancer
- Hereditary Paraganglioma
- Male Breast Cancer
- Malignant Paraganglioma
- Metastatic Gastrointestinal Carcinoid Tumor
- Metastatic Pheochromocytoma
- Pancreatic Polypeptide Tumor
- Recurrent Breast Cancer
- Recurrent Cervical Cancer
- Recurrent Endometrial Carcinoma
- Recurrent Gastrointestinal Carcinoid Tumor
- Recurrent Islet Cell Carcinoma
- Recurrent Neuroendocrine Carcinoma of the Skin
- Recurrent Non-small Cell Lung Cancer
- Recurrent Ovarian Epithelial Cancer
- Recurrent Ovarian Germ Cell Tumor
- Recurrent Pheochromocytoma
- Recurrent Prostate Cancer
- Recurrent Renal Cell Cancer
- Recurrent Small Cell Lung Cancer
- Recurrent Uterine Sarcoma
- Regional Gastrointestinal Carcinoid Tumor
- Regional Pheochromocytoma
- Stage III Cervical Cancer
- Stage III Endometrial Carcinoma
- Stage III Neuroendocrine Carcinoma of the Skin
- Stage III Ovarian Epithelial Cancer
- Stage III Ovarian Germ Cell Tumor
- Stage III Prostate Cancer
- Stage III Renal Cell Cancer
- Stage III Uterine Sarcoma
- Stage IIIA Breast Cancer
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Breast Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Stage IIIC Breast Cancer
- Stage IV Breast Cancer
- Stage IV Endometrial Carcinoma
- Stage IV Neuroendocrine Carcinoma of the Skin
- Stage IV Non-small Cell Lung Cancer
- Stage IV Ovarian Epithelial Cancer
- Stage IV Ovarian Germ Cell Tumor
- Stage IV Prostate Cancer
- Stage IV Renal Cell Cancer
- Stage IV Uterine Sarcoma
- Stage IVA Cervical Cancer
- Stage IVB Cervical Cancer
- Thyroid Gland Medullary Carcinoma
Interventions
- DRUG: temsirolimus
- DRUG: vinorelbine ditartrate
Sponsor
University of Southern California
Collaborators